Stem Cell Research (Mar 2021)

Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7

  • Zhi-ting Chen,
  • Zhen-hua Zhao,
  • Li-na Chen,
  • Fei Fan,
  • Guo-en Cai,
  • Hui-dan Weng,
  • Ying-qing Wang,
  • Lian-ming Liao,
  • Xiao-chun Chen,
  • En Huang,
  • Qin-yong Ye

Journal volume & issue
Vol. 51
p. 102175

Abstract

Read online

PARK7 mutations are accountable for the inherited Parkinson's disease. An induced pluripotent stem cell (iPSC) line FJMUUHi001-A was generated by expressing five reprogramming factors, OCT3/4, SOX2, c-MYC, KLF4 and BCL-XL, in peripheral blood mononuclear cells from a 32-year old patient carrying a homozygous mutation of c.189dupA in PARK7. The iPSCs with a normal karyotype had the abilities to differentiate into three germ layers and expressed pluripotency markers without detectable residual plasmids. The cell line FJMUUHi001-A carrying the truncating protein PARK7 could be a useful tool to help comprehend the function of PARK7 in the iPSCs and differentiated cells from them.